Target intelligence / Profile preview

Large conductance calcium-activated potassium channel SLO-1 (SLO-1)

Target
SLO-1
Molecular classification
Ion channel, Potassium channel, Calcium-activated potassium channel, Voltage-gated potassium channel
01

Overview

The Large conductance calcium-activated potassium channel SLO-1, also known as the BK channel, is a critical regulator of cellular excitability in both neurons and muscle cells [1, 13]. It is uniquely gated by both membrane depolarization and increases in intracellular calcium concentration, allowing it to integrate electrical and chemical signals to modulate repolarization [13, 18]. In nematodes, SLO-1 is the primary molecular target for the anthelmintic drug emodepside, which activates the channel to cause hyperpolarization and flaccid paralysis [2, 3]. While essential for parasite control, the channel's human ortholog, KCNMA1, is involved in vital processes such as smooth muscle relaxation and neurotransmitter release [13, 16]. Consequently, therapeutic strategies targeting SLO-1 must achieve high selectivity to avoid host toxicities associated with human BK channel dysfunction, such as epilepsy or movement disorders [13, 16]. Therapeutic development focuses on exploiting structural differences between nematode and mammalian channels to ensure safety [2, 12].

Other names
BK channelMaxi-K channelKCa1.1Slowpoke homolog 1KCNMA1Calcium-activated potassium channel subunit alpha-1
02

Mechanism of action

Emodepside acts as a potent activator of the SLO-1 channel, increasing its open probability and leading to a massive efflux of potassium ions. This causes membrane hyperpolarization, which inhibits neuronal and muscle activity, resulting in flaccid paralysis and death of the nematode [1, 2, 4].

03

Biological functions

Regulation of membrane potentialNeurotransmitter releaseMuscle contractionCell excitabilityRepolarization of excitable cells
04

Disease associations

HelminthiasisEpilepsyMovement disordersLiang-Wang syndromeHypertension
05

Safety considerations

Off-target activation of human KCNMA1 (BK) channelsPotential neurological side effects such as seizures or movement disordersCardiovascular effects due to BK channel activation in smooth muscleDevelopment of anthelmintic resistance in parasite populations
06

Interacting drugs

Emodepside

5 more in the full profile.

07

Biomarkers

KCNMA1 genetic variantsSLO-1 expression levels

Beyond the preview

Go deeper on Large conductance calcium-activated potassium channel SLO-1 (SLO-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large conductance calcium-activated potassium channel SLO-1 (SLO-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call